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Abstract 
The combined effect of two linear inhibitors of rat liver alkaline phosphatase (ALP). 
vanadate (Van) and L-phenylalanine (L-phe) were studied using a modification of 
the common Yonetani-Theorell procedure proposed for studying synergistic 
inhibition. The modes of inhibition of ALP by Van and L-phe as analysed using the 
double reciprocal plots of the Michaelis-Menten equation were mixed and 
uncompetitive inhibition respectively. Analysis of the combined effect of the two 
inhibitors showed that their inhibitory effects were mutually enhanced. The 
mechanistic aspects and practical applications of the procedure are discussed. 
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Kinetic and mechanistic studies on the combined 
effect of two linear inhibitors on a single enzyme 
are of vital interest. It is often necessary to 
determine if different inhibitors bind to the same 
site on an enzyme. Such exclusive binding is 
often investigated by examining how the enzyme 
responds to the simultaneous effect of both 
inhibitory ligands. (Cook et al, 1994) The 
mechanisms of catalysis of enzymes forming 
ternary complexes have also been investigated 
using this strategy. (Reckskowski and Ash, 1994) 
Of vital importance is the potential for enhanced 
chemotherapeutic effect when two different 
antagonists enhance their mutual effects when 
applied to a receptor. Positive synergistic 
interactions have been reported as a possible new 
strategy in optimizing chemotherapeutic effects 
(Scholten et al, 1997) and it is likely that synergy 
will receive greater attention in the coming years 
as a practical strategy in rational drug design. It is 
therefore important to gain proper insight into the 
mechanism of synergistic interactions.   
 
Synergistic response is obtained when the 
combined effect of two agents deviates from that 
expected from the dose-response curves of the 
agents. Hence, the terms ‘positive synergism’ and 
‘negative synergism’ describe situations in which 
the two inhibitors enhance and decrease their 
effects respectively. Positive synergism is often 
simply referred to as synergy and negative 
synergism as antagonism.  
 
Several kinetic models have been proposed for 
the analysis of the combined effects of two or 
more inhibitors on the same enzyme. (Martinez-
Irujo et al, 1998) Perhaps the most  
 
 
widely used of the procedures is that of Yonetani 
and Theorell. (See Martinez-Irujo et al, 1998) 
This treatment leads to the generation of a 
‘synergism factor’ γ  , the value of which 
provides information on the type of synergistic 
interaction or its absence. Factor γ describes the 
mutual influence of the two agents on the binding 
and effect of one another. Inhibitor binding and 
hence effect is independent when γ is 1, while 
values of γ greater or lower than 1 represents 
mutual antagonism and enhancement 
respectively.  
 
The analysis of combination effects by the 
method of Yonetani and Theorell involves 
determining the combined effect of both 
inhibitors under the condition of keeping one 
inhibitor concentration constant and varying 
that of the second. The requirement to have 
knowledge of the mechanism of inhibitor action 
via steady state kinetics is a limitation of this 
procedure and results obtained have often 
proved to be meaningful only when interpreted 
in the light of the inhibitors’ mechanism of 
action. Several attempts have been made to 
simplify the analysis of combined inhibition 
with a view to reduce the amount of data 
needed for the analysis and to make the results 
obtained mechanism-compliant as much as 
possible.  Martinez-Irujo et al (1998) proposed 
a modification of the Yonetani-Theorell plot in 
which the IC50 of the inhibitor whose 
concentration is kept constant is incorporated in 
the analysis.  
 
Here, we have applied the modified procedure 
of Martinez-Irujo to investigate possible 
synergism in the effect of two linear inhibitors 




MATERIALS AND METHODS 
Reagents, chemicals and enzyme substrates 
p-nitrophenylphosphate was obtained from 
Sigma Chemical Company, St. Louis, US. 
Sodium salt of vanadate and L-phenylalanine 
were products of British Drug House, Poole, 
UK. All other chemicals used in the study were 
of high quality research grade.  
  
Preparation of rat liver alkaline phosphatase 
Crude homogenates of rat liver was 
concentrated for ALP activity using ammonium 
sulphate according to a modified procedure of 
Hung & Melnykovych (1977). Rat liver was 
homogenized in 0.25M sucrose solutions at 4oC 
and the crude homogenate was centrifuge at 
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5000 rpm for 20 minutes at the same temperature. 
To the supernatant fraction was added a 0.55g/ml 
(4.17M) solution of (NH4)2SO4 gradually with 
stirring until 30% saturation was reached. Further 
granules of (NH4)2SO4 were added slowly until 
50% saturation was achieved. The precipitate was 
collected by centrifugation at 5000 rpm for 20 
minutes and re-dissolved in 0.1M carbonate-
bicarbonate buffers, pH 10.1. The activities of the 
ALP prepared this way and used in this study 
were highly reproducible and gave linear results 
with a correlation level sufficient for kinetic 
work. 
Determination of ALP activities   
Alkaline phosphatase activity was measured by 
the rate of hydrolysis of 5mM p-nitrophenyl 
phosphate (pNPP) at 25oC in 0.1M 
Na2CO3/NaHCO3 buffers, pH 10.1 as previously 
described (Ahlers, 1975). Enzyme activity is 
expressed as the µM of p-nitrophenol released per 
minute. Protein concentration was determined 
using the Folin-phenol method of Lowry et al 
(1951) with Bovine Serum Albumin (BSA) as 
standard.  Spectrophotometric readings were 
taken on Spectronic 21 UV-VIS 
spectrophotometer. 
 
Determination of IC50 from dose-response 
curve of Vanadate and kinetics of inhibition by 
Vanadate and Phenylalanine  
In order to determine the concentration-
dependent effect of Van on ALP activity, various 
concentrations of Van were included in the 
enzyme reaction mixture and the corresponding 
activities were recorded. The data were fitted to a 
dose-response curve according to the following 




Where f is the fractional inhibition exerted by 
[Van], 
 
             f = (vo-vi)/vo 
 
and IC50 is the concentration of the inhibitor that 
caused 50% inhibition of the enzyme activity. 
The IC50 value could be read directly from the 
plot as the [Van] giving an f value of 0.5. For a 
more accurate and definite determination of 
IC50, we transformed the equation by plotting 
1/f against1/ [Van]. This gave a straight line 
with a y-intercept of unity and a slope 
corresponding to the IC50 value. We found that 
the two approaches gave very close values for 
the parameter. In order to determine the effects 
of Van and L-phe on Michaelis-Menten kinetic 
constants, Km and Vmax of the liver ALP, the 
substrate-dependent change in enzyme activity 
was studied in the absence and presence of the 
inhibitors separately. Kinetic constants were 
determined using the Enzfitter computer 
software (Elsevier-Biosoft) 
 
Measurement of the combined effects of Van 
and Phe 
The presence and nature of synergy or 
otherwise in the combined effect of Van and L-
phe were investigated according to the 
procedure of (Martinez-Irujo et al, 1998). The 
ratio of uninhibited reaction to the inhibited 
(Vo/Vi) was determined at fixed concentrations 
of L-phe and varied concentrations of Van and 
plotted against [Van]/IC50 at the different fixed 
concentrations of L-phe.  
 
The behaviour of two inhibitors with the 
potential to affect each others binding and 
effects is given by the expression (Martinez-









 at various I2  



























































































For the specific case in which I1 is a mixed 
inhibitor and I2 an uncompetitive inhibitor as is 




























This generated a series of lines each representing 
the fixed concentrations of L-phe. The lines 




where α represent the change in substrate affinity 
induced by Van; Ks, the enzyme-substrate 
dissociation complex; and factor γ represents the 
mutual influence of the two inhibitors on the 
binding of each other. Factor α is calculated from 
the ratio of Km values for the inhibited and 
uninhibited reactions 
 
RESULTS & DISCUSSION  
 
The dose-response curves for the inhibitory effect 
of Van and is shown in Figure 1A. The pattern of 
inhibition displayed a hyperbolic shape indicating 
that inhibition of ALP by Van was a saturable 
process. The double reciprocal transformation of 
the curve shown in Figure 1b was a straight line 
from which the slope of 85.47µM corresponding 
to the IC50 was determined. This value was 
essentially equal to that of 85. 53µM read directly 
from the curve in Figure 1A. It is recommended 
that the double reciprocal plot be used in 
determining the IC50 value as this gives an 
unambiguous value read directly from the slope 
of the curve.  
 
The kinetics of inhibition by Van and L-phe were 
also investigated independently and the results 
are shown in Figure 2. From the double 
reciprocal plot shown in figure 2A, it is evident 
that Van is a mixed inhibitor of rat liver ALP. 
The Km and Vmax of ALP were decreased from 
7.81 to 2.28mM and from 0.45 to 0.09 
respectively. The calculated inhibition constants 
from the plots were 4µM and 26.7µM for kiu and 
kic respectively.  The inhibition constants, kic 
and kiu, represent the binding affinities of the 
inhibitor to the free enzyme and the enzyme-
substrate complex respectively (Segal, 1975) It 
appears from the results that the affinity of Van 
for the ES complex is higher than its binding 




























Figure 1:  Dose-response curve for the effect of vanadate on rat 
liver alkaline phosphatase. The data in A is plotted in a linearized 
form in B allowing the easy determination of IC50 from the slope 
of the line. 
 
The inhibitory effect of vanadate for phosphate-
metabolizing enzymes has been ascribed to its 
ability to mimic the anionic character of 
inorganic phosphate. (Stankiewicz et al, 1995) 
In fact, a mutual antagonistic effect between 
vanadate and phosphate appears to be a 
fundamental principle in metalloenzymology. It 
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has been shown that vanadate-containing 
haloperoxidases rapidly lose their activity in 
phosphate-containing buffers and that 
reconstitution of the apoenzyme of 
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Figure 2:  Double reciprocal plots for the inhibition of rat liver 
alkaline phosphatase by vanadate and L-phenylalanine. 
 
presence of phosphate. (Tromp et al, 1991). 
These reports strongly suggest a common binding 
site for vanadate and phosphate in 
haloperoxidases and phosphatases. One may thus 
expect that inhibition of ALP by vanadate would 
follow a strictly competitive mode. Mixed 
inhibition of ALP by vanadate reported in this 
study might be examined in the light of a report 
by Shirazi et al (1981) who observed deviation 
from competitive inhibition, and in fact, 
tendency toward mixed inhibition by a series of 
phosphate analogues. The authors suggested 
that the ability of some of the analogues to 
serve as weak substrates of the enzyme might 
account for the observed deviations. Perhaps 
there is the need to analyze the pattern of 
vanadate inhibition of rat liver ALP via other 
procedures with finer mechanistic ‘resolution 
power’ 
 The enhanced binding of ALP-pNPP complex 
as seen from this study may suggest that 
vanadate inhibition of ALP may involve other 
mechanisms apart from competition with 
phosphate for binding to the active center. 
 
Figure 2B shows that, in contrast to Van, L-phe 
was an uncompetitive inhibitor of ALP. The 
parallel orientation of the line representing the 
inhibited reaction with that of the uninhibited 
one is diagnostic of uncompetitive inhibition 
(Cornish-Bowden, 1995) This agrees with 
earlier reports that rat intestinal alkaline 
phosphatase is inhibited uncompetitively by L-
phenylalanine (Ghosh and Fishman, 1966; 
Hoylaerts et al, 1992) One diagnostic and 
crucial test for uncompetitive inhibition is that 
the inhibitor decreases the Km and Vmax by 
the same factor.  As shown in Table 1, L-phe 
decreased the Km and Vmax of ALP by similar 
ratios of 0.20 and 0.29 respectively. The 
seeming disparity observed in this study can be 
explained on the basis of deviations due to 
experimental error. One may point out 
however, that the values are reasonably close 
enough to substantiate diagnosis of 
uncompetitive inhibition rather than other 
possibilities. The selective binding of the ALP-
pNPP complex by L-phe as implied by its 
uncompetitive mode of action is of some 
interest. Uncompetitive mode of enzyme 
inhibition is extremely rare in single substrate 
reactions. The reported cases of uncompetitive 
inhibition of ALP by L-phe may provide 
opportunities for characterizing the mechanistic 
basis for uncompetitive enzyme inhibition. In 
the case under consideration, perhaps it would 
be interesting to investigate what amino acid 
residues are exposed for hydrophobic 
interactions in ALP after the substrate is bound.  
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- - - - 
Van 2.28 0.09 4.00 26.67 0.29 0.20 
L-phe 0.99 0.05 2.50 - 0.13 0.11 
 
 
The different, almost exclusive mode of 
inhibition of ALP by Van and L-phe makes them 
suitable candidates for synergistic interactions in 
combined inhibition studies. Martinez-Irujo et al 
(1998) suggested a modification of the Yonetani-
Theorell plot for studying facilitation or 
hindrance when two different inhibitors 
simultaneously act on the same enzyme. The 
authors tested the fitness of the model by 
analyzing data on the effects of adenosine 
diphosphate and o-phenanthroline on horse liver 
ethanol dehydrogenase. The two inhibitors 
studied were competitive inhibitors of the 
enzyme and the results obtained from the synergy 
analysis agreed well with the original Yonetani-
Theorell analysis. In this study, the suggested 
method of Martinez-Irujo et al (1998) was used 
in analyzing the combined effect of Van and L-
phe.  
 
Figure 3 shows the combined effects of the two 
inhibitors (Van and L-phe) on rat liver ALP. The 
intersection point of the three lines gave a value 
of –0.261 on the [Van]/(IC50)Van axis from 
which a value of 0.08 was calculated for factor γ. 
This value indicates a positive interaction in the 
combined effect of Van and L-phe in the 
inhibition of ALP. It is noteworthy that the three 
lines did not give a perfect meeting point for the 
estimation of γ. However the average value was 
taken by solving the simultaneous equation of the 
lines of best fit passing through the data points. 
Inability to generate a perfect meeting point for 
the lines can be attributed to the limitations 
imposed by working with partially purified 
enzyme preparations. Ahlers (1975) pointed out 
the advantage of limited purification of tissue 
ALP in studies designed for kinetic  
 
measurements. In order to carry out such 
studies under reproducible conditions, it was 
pointed out that it is better to have large 
stabilized enzyme preparations than small 




















Figure 3: Combined effect of vanadate and L-phenylalanine on 
rat liver alkaline phosphatase. 
 
In a study on human placental and germ-cell 
alkaline phosphatase, the molecular mechanism 
of uncompetitive inhibition by L-phe was 
linked to its ability to bind to an arginine 
residue in the active site of the enzyme 
(Hoylaerts et al, 1992) The authors proposed, 
based on data from recombinant enzyme in 
which site directed mutagenesis were carried 
out, that after binding the phosphorylated 
substrate to the active site, the guanidium group 
of Arg-166 that is normally involved in 
positioning phosphate is redirected to the 
carboxyl group of L-phe, thus stabilizing the 
inhibitor at the active site.  Bearing in mind the 
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highly anionic character of vanadate, we are 
suggesting that the mutual enhancement of 
inhibition by both Van and L-phe may be 
rationalized on the basis of that report. The 
negative groups of Van after it is bound to the 
enzyme active site may create a ‘docking site’ for 
binding by L-phe. This, of course presumes that 
Van binds obligatorily before L-phe when both 
are simultaneously exposed to the enzyme. The 
competitive mode of inhibition postulated for 
vanadate inhibition of ALP in earlier studies 
(Ghosh and Fishman, 1966; Hoylaerts et al, 
1992) and the mixed mechanism we found in this 
study indeed show that it is likely that Van binds 
before L-phe. However, there is no direct 
evidence yet to substantiate this assumption.  
 
Hoylaerts et al (1992) also suggested that 
uncompetitive inhibition of human ALP by L-phe 
might result from coordination of the amino acid 
unprotonated amino group with the active site 
Zn2+ ion, thereby interfering with the hydrolysis 
of the phosphoenzyme intermediate. This is of 
significant interest in explaining the mutual 
enhancement of the inhibitory effect of Van 
and L-phe. Vanadates with its negative 
character can readily complex Zn2+ and other 
divalent metal ions present in the enzyme and 
necessary for catalytic activity. 
 
The findings from this study proved that the 
procedure of Martinez-Irujo et al (1998) for 
detecting and characterizing synergistic 
interactions in combined inhibition could also 
be applied to cases in which the inhibitors act 
via different mechanisms. However, it is still 
important to develop analytical procedures that 
do not rely on the mechanism of inhibition of 
either of the combined inhibitors. Progress in 
this direction will definitely facilitate the use of 
combined inhibitors in chemotherapy and other 
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